[Regulation of psychomotor functions by dopamine: integration of various approaches].
(1)The basal ganglia circuitry mediates a wide rage of brain functions such as motor control, behavioral planning, and reward prediction. Dopamine (DA) transmission plays an essential role in the regulation of these brain functions. DA action not only regulates the firing activity of target neurons but also is involved in the pattern formation of their firing. The striatopallidal neurons containing dopamine D(2) receptor plays a dual role in motor coordination dependent on DA transmission. (2)Activation of presynaptic D(2)-like receptors on GABAergic terminals onto striatal cholinergic interneurons selectively blocks N-type Ca(2+) channels, thereby inhibiting GABA release. In addition, contribution of N-type channels and D(2)-like receptor-mediated presynaptic inhibition decreases in parallel with development, implying some relationship between basal ganglia-related function or dysfunction and age. (3)As an approach to determine dopamine neuronal activity, we monitored neuronal activities by measuring cytosolic Ca(2+) concentration in VTA dopamine neurons. The present study indicates that VTA dopamine neurons are the direct targets of orexin-A and psychostimulants, and the [Ca(2+)](i) signaling is thought to play a significant role in the regulation of dopamine neuronal activity. (4)The excitability of neostriatal neurons is regulated by a balance of glutamatergic and dopaminergic inputs. Glutamate has been shown to modulate dopaminergic signaling. Studies on the regulation of DARPP-32 phosphorylation by glutamate provide a molecular basis for both the synergistic and antagonistic effects of glutamate on dopaminergic signaling. (5) Impairment of function of stem/progenitor cells may be implicated in the pathogenesis of schizophrenia. To test this hypothesis, several experiments are currently ongoing in our laboratory, and the preliminary results obtained are described here.
Sasa
Masashi
M
Nagisa Hospital, Nagasaminami, Hirataka, Japan.
Nishi
Akinori
A
Kobayashi
Kazuto
K
Sano
Hiromi
H
Momiyama
Toshihiko
T
Uramura
Kazuhide
K
Yada
Toshihiko
T
Mori
Norio
N
Suzuki
Katsuaki
K
Minabe
Yoshio
Y
D000818:Animals; D001921:Brain / Q000502:physiology*; D002118:Calcium / Q000378:metabolism; D020864:Calcium Channels, N-Type / Q000502:physiology; D020013:Calcium Signaling / Q000502:physiology; D004298:Dopamine / Q000502:physiology*; D051937:Dopamine and cAMP-Regulated Phosphoprotein 32; D005971:Glutamates / Q000502:physiology; D006801:Humans; D009419:Nerve Tissue Proteins; D010750:Phosphoproteins / Q000502:physiology; D011597:Psychomotor Performance / Q000502:physiology*; D017448:Receptors, Dopamine D2 / Q000502:physiology; D017470:Receptors, Glutamate / Q000502:physiology; D012559:Schizophrenia / Q000209:etiology; D009435:Synaptic Transmission / Q000502:physiology
D020864:Calcium Channels, N-Type; D051937:Dopamine and cAMP-Regulated Phosphoprotein 32; D005971:Glutamates; D009419:Nerve Tissue Proteins; D010750:Phosphoproteins; D017448:Receptors, Dopamine D2; D017470:Receptors, Glutamate; D002118:Calcium; D004298:Dopamine